Health guidelines set for pilgrimage to be attended by 1 million people Saudi Arabia has specified 10 vaccines against COVID-19 for pilgrims who will perform this year’s Hajj. The Saudi Health Ministry announced the names and required dos..
North Korea has ordered a strict national lockdown after confirming its first official Covid infections. State media have reported an Omicron outbreak in the capital, Pyongyang, but did not state the number of cases. KCNA said leader Kim Jong-u..
Under its neutral vaccination monitoring programme in Syria, Qatar Red Crescent Society (QRCS) has commenced monitoring Phase 2 of the World Health Organization’s COVID-19 vaccination campaign in northern Syria. It’s part of the COVID-19 ..
India will offer booster doses of COVID-19 vaccine to all adults from Sunday, although free third doses will be limited to frontline workers and those older than 60 who get them at government centres. The country has given 1.85 billion vaccine dos..
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Antibodies in kids after COVID last 6 months or more M..
AstraZeneca (AZN.L) said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose. The increased response..
India started vaccinating children aged 15 to 18 against the coronavirus on Monday as it quickly expands its inoculation effort to cover the world's largest adolescent population amid fears the Omicron variant will drive a new surge of infections..
According to recent statistics from the UK Health Security Agency, a booster vaccine is 88 percent effective in preventing people from being hospitalized with Covid-19. The current research reveals that two doses of the Omicron vaccines from Astra..
Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company's chief executive said on Friday. Serum Institute, which produces AstraZeneca..